The Scientific Publications section of CD BioSciences provides expert analysis and curated commentary on peer-reviewed research articles focused on human herpesviruses (HHVs). Rather than hosting our own publications, this resource is designed to interpret and contextualize important external scientific studies, offering concise and accurate overviews for our clients and collaborators in the life sciences sector.
We monitor high-impact journals and leading research groups to identify key advancements across a range of HHV-related topics, including:
- Novel antiviral targets and mechanisms
- Preclinical efficacy studies and animal models
- Insights into HHV latency, reactivation, and immune evasion
- Progress in HHV vaccine development and delivery platforms
- Applications of oncolytic herpesviruses in cancer therapy
Each featured article is summarized and reviewed by our scientific team to highlight its implications for preclinical research and therapeutic development. These expert summaries are designed to support decision-making, reduce information overload, and facilitate faster translation of scientific findings into actionable R&D strategies.
By staying current with the latest literature, our readers gain a competitive edge in designing experiments, selecting models, and aligning their research with emerging trends in HHV biology and treatment.